Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinoma.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 22622510)

Published in Pharm Res on May 24, 2012

Authors

Orazio Vittorio1, Giuseppe Cirillo, Francesca Iemma, Giovanni Di Turi, Emanuela Jacchetti, Michele Curcio, Serena Barbuti, Niccola Funel, Ortensia Ilaria Parisi, Francesco Puoci, Nevio Picci

Author Affiliations

1: NEST Scuola Normale Superiore & Istituto Nanoscienze-CNR Piazza San Silvestro, 56126 Pisa, Italy.

Articles by these authors

PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer. J Clin Oncol (2009) 3.48

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res (2006) 2.38

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res (2010) 2.22

Real-time quantitative polymerase chain reaction analysis of patients with refractory chronic periodontitis. J Periodontol (2010) 1.99

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One (2010) 1.96

LANCL2 is necessary for abscisic acid binding and signaling in human granulocytes and in rat insulinoma cells. J Biol Chem (2009) 1.15

Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression. Apoptosis (2008) 1.10

Biological activity of a gallic acid-gelatin conjugate. Biomacromolecules (2010) 1.06

Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells. Cancer Lett (2009) 1.03

High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer. PLoS One (2012) 1.02

Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. Mol Cancer Ther (2012) 0.98

Covalent insertion of antioxidant molecules on chitosan by a free radical grafting procedure. J Agric Food Chem (2009) 0.97

A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function. Clin Cancer Res (2008) 0.97

Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95

Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma. Cancer Res (2013) 0.95

Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm (2007) 0.94

Characterization of the S-denitrosylating activity of bilirubin. J Cell Mol Med (2009) 0.94

Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter. Epigenetics (2011) 0.93

BDNF regulates the expression and distribution of vesicular glutamate transporters in cultured hippocampal neurons. PLoS One (2013) 0.91

Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression. J Nutr Biochem (2010) 0.91

Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours. Eur Radiol (2014) 0.90

Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer. Clin Cancer Res (2011) 0.89

Autocrine abscisic acid plays a key role in quartz-induced macrophage activation. FASEB J (2011) 0.88

Excitotoxic stimulation downregulates the ubiquitin-proteasome system through activation of NMDA receptors in cultured hippocampal neurons. Biochim Biophys Acta (2012) 0.88

Magnetic carbon nanotubes: a new tool for shepherding mesenchymal stem cells by magnetic fields. Nanomedicine (Lond) (2011) 0.88

Grafted thermo-responsive gelatin microspheres as delivery systems in triggered drug release. Eur J Pharm Biopharm (2010) 0.87

Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol Nutr Food Res (2010) 0.87

New sucrose cocoate based vesicles: Preparation, characterization and skin permeation studies. Colloids Surf B Biointerfaces (2009) 0.86

Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf B Biointerfaces (2013) 0.86

pH-sensitive hydrogels based on bovine serum albumin for oral drug delivery. Int J Pharm (2006) 0.85

Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling. Stem Cells Dev (2010) 0.85

The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells. Carcinogenesis (2008) 0.85

Potential of olive oil phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies. Mol Nutr Food Res (2012) 0.84

Neuroprotection by GDNF in the ischemic brain. Growth Factors (2012) 0.84

Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of beta-carotene and alpha-tocopherol. Colloids Surf B Biointerfaces (2009) 0.84

Synthesis of antioxidant polymers by grafting of gallic acid and catechin on gelatin. Biomacromolecules (2009) 0.83

Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset. Sci Rep (2013) 0.83

miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells. Nucleosides Nucleotides Nucleic Acids (2014) 0.82

Molecularly imprinted polymers as drug delivery systems for the sustained release of glycyrrhizic acid. J Pharm Pharmacol (2010) 0.82

The odd case of a small and mucinous-like acinar cell cystoadenocarcinoma of the pancreas. Pancreatology (2012) 0.82

Endothelial differentiation of mesenchymal stromal cells: when traditional biology meets mechanotransduction. Integr Biol (Camb) (2013) 0.82

Negative thermo-responsive microspheres based on hydrolyzed gelatin as drug delivery device. AAPS PharmSciTech (2010) 0.82

Synthesis of methacrylic-ferulic acid copolymer with antioxidant properties by single-step free radical polymerization. J Agric Food Chem (2008) 0.82

Silica-based mesoporous materials as drug delivery system for methotrexate release. Drug Deliv (2007) 0.82

Role of CYB5A in pancreatic cancer prognosis and autophagy modulation. J Natl Cancer Inst (2013) 0.82

Cell-free DNA in the plasma of patients with systemic sclerosis. Clin Rheumatol (2009) 0.82

Retracted Redox regulation of 7-ketocholesterol-induced apoptosis by beta-carotene in human macrophages. Free Radic Biol Med (2007) 0.82

Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer. Curr Pharm Des (2013) 0.82

Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: an open-label, multicentre, prospective trial on 180 patients. Curr Med Res Opin (2003) 0.82

Antioxidant effect of ferulic acid in isolated membranes and intact cells: synergistic interactions with alpha-tocopherol, beta-carotene, and ascorbic acid. J Agric Food Chem (2004) 0.82

Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2. Biomaterials (2010) 0.81

Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. Biomatter (2014) 0.81

Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm. Biomed Pharmacother (2006) 0.81

In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1/G93A(+) mouse model of amyotrophic lateral sclerosis. J Neurochem (2010) 0.81

Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy. Pharmacogenomics (2011) 0.81

Imaging intracellular viscosity by a new molecular rotor suitable for phasor analysis of fluorescence lifetime. Anal Bioanal Chem (2013) 0.80

Alkylamino derivatives of 4-aminomethylpyridine as inhibitors of copper-containing amine oxidases. J Med Chem (2005) 0.80

Vascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatment. PLoS One (2013) 0.80

Solubilization and stabilization of beta-carotene in niosomes: delivery to cultured cells. Chem Phys Lipids (2005) 0.80

The protective role of carotenoids against 7-keto-cholesterol formation in solution. Mol Cell Biochem (2007) 0.80

Starch-quercetin conjugate by radical grafting: synthesis and biological characterization. Pharm Dev Technol (2011) 0.80

Niosomes from alpha,omega-trioxyethylene-bis(sodium 2-dodecyloxy-propylenesulfonate): preparation and characterization. Colloids Surf B Biointerfaces (2008) 0.80

Retracted Design, synthesis, and antioxidant potency of novel alpha-tocopherol analogues in isolated membranes and intact cells. Free Radic Biol Med (2008) 0.80

L-lysine pro-prodrug containing trans-ferulic acid for 5-amino salicylic acid colon delivery: synthesis, characterization and in vitro antioxidant activity evaluation. Chem Pharm Bull (Tokyo) (2010) 0.79

Anticancer activity of a quercetin-based polymer towards HeLa cancer cells. Anticancer Res (2012) 0.79

Antioxidant multi-walled carbon nanotubes by free radical grafting of gallic acid: new materials for biomedical applications. J Pharm Pharmacol (2010) 0.79

Molecularly imprinted polymers for alpha-tocopherol delivery. Drug Deliv (2008) 0.79

Transferrin-conjugated pluronic niosomes as a new drug delivery system for anticancer therapy. Langmuir (2013) 0.79

Molecularly imprinted polymers for 5-fluorouracil release in biological fluids. Molecules (2007) 0.79